Pharmaceutical Information |
Drug Name |
Loxapine succinate |
Drug ID |
BADD_D01327 |
Description |
An antipsychotic agent used in schizophrenia. [PubChem] |
Indications and Usage |
For the management of the manifestations of psychotic disorders such as schizophrenia |
Marketing Status |
Prescription; Discontinued |
ATC Code |
N05AH01 |
DrugBank ID |
DB00408
|
KEGG ID |
D00794
|
MeSH ID |
D008152
|
PubChem ID |
71399
|
TTD Drug ID |
D0U5OE
|
NDC Product Code |
64330-112; 53296-0017 |
Synonyms |
Loxapine | 2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine | Oxilapine | Cloxazepine | Loxapine Hydrochloride | Hydrochloride, Loxapine | Loxitane | Loxapine Succinate | Succinate, Loxapine | Loxapinsuccinate | Loxipine Succinate | Loxipine Maleate | Maleate, Loxipine | CL-71,563 | CL 71,563 | CL71,563 | Loxapine Monohydrochloride |
|
Chemical Information |
Molecular Formula |
C22H24ClN3O5 |
CAS Registry Number |
27833-64-3 |
SMILES |
CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
|